Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases - De Stefano, V; Rossi, E; Carobbio, A (Blood Cancer J, 2018)